The Journal of Thoracic and Cardiovascular Surgery
Thoracic: EducationGender trends in cardiothoracic surgery authorship
Graphical Abstract
Section snippets
Methods
We performed a cross-sectional bibliometric analysis, identifying works published in the 2 highest impact factor cardiothoracic surgery-focused journals—the Annals of Thoracic Surgery and the Journal of Thoracic and Cardiovascular Surgery—between January 2011 and December 2020. Associated citation data were downloaded and used to identify journal, year of publication, and first and last author names. Given the use of publicly available data, this study was exempt from institutional review board
Results
We performed an interim sensitivity analysis to evaluate our initial exclusion criteria (less than 90% gender “probability” or fewer than 100 occurrences within the gender inference software database). Author names associated with women were present within the Gender-API inference database, on average, 28,090 times, whereas names associated with men were present 47,509 times (P < .001). Among author names categorized as woman-associated, the average gender probability was 90.81%, whereas for
Discussion
Gender imbalances in the practice of medicine have existed since its inception. Cardiothoracic surgery, holding a long history as a heavily male-skewed subspecialty, is no different. The first women surgeons were certified by the American Board of Thoracic Surgery in 1961, and Dr Nina Starr Braunwald became the first woman to be elected to the AATS in 1967.12,13 Today, more than 50 years later, women still comprise less than 10% of the cardiothoracic surgeon workforce.5 Despite this, there has
Conclusions
In the last 10 years, overall authorship by women in the cardiothoracic surgery literature has increased, and women publish at a rate greater than their presence within the field of cardiothoracic surgery. Publication is more frequent and is growing faster in the first author position than in the last author position (Figure 3). As a field, we should take this finding as a call for ongoing focused support and mentorship of early and mid-career women cardiothoracic surgeons as they transition to
References (27)
- et al.
Representation of women in the Society of Thoracic Surgeons authorship and leadership positions
Ann Thorac Surg
(2020) - et al.
Women and minorities underrepresented in academic cardiothoracic surgery: it's time for next steps
Ann Thorac Surg
(2021) Equal means equal: cardiothoracic surgery in its second century
J Thorac Cardiovasc Surg
(2021)- et al.
2020 women in thoracic surgery update on the status of women in cardiothoracic surgery
Ann Thorac Surg
(2022) - et al.
The importance of a diverse specialty: introducing the STS Workforce on Diversity and Inclusion
Ann Thorac Surg
(2019) - et al.
Culture of safety and gender inclusion in cardiothoracic surgery
Ann Thorac Surg
(2018) - et al.
Trends in female authorship: a bibliometric analysis of the Annals of Thoracic Surgery
Ann Thorac Surg
(2021) - et al.
Gender differences in academic medicine: retention, rank, and leadership comparisons from the national Faculty survey
Acad Med
(2018) - et al.
Promotion of women physicians in academic medicine. Glass ceiling or sticky floor?
JAMA
(1995) - et al.
Sex differences in faculty rank among academic surgeons in the United States in 2014
Ann Surg
(2018)
2021 FACTS: Applicants and Matriculants Data
The national and global impact of “women in thoracic surgery”.
J Thorac Dis
Cited by (3)
Differential gender-based experiences of cardiothoracic surgeons: Time to change our alternate realities
2024, Journal of Thoracic and Cardiovascular SurgeryA welcome trend: Authorship in cardiothoracic surgery
2023, Journal of Thoracic and Cardiovascular SurgeryCommentary: Equity in cardiothoracic authorship: Are we there yet?
2023, Journal of Thoracic and Cardiovascular Surgery
All aspects of this project were funded internally. R.B. receives or has received support for his research from Verastem, Genetech/Roche, Myriad Genetics, Novartis, Siemens, Gritstone, Epizyme, MedGenome, Merck, Bicycle Therapeutics, Bayer, Intuitive Surgical, Northpond, the National Cancer Institute, the National Institutes of Health, the Department of Defense, the National Institute of Biomedical Imaging and Bioengineering, and the National Heart, Lung, and Blood Institute.